Nov 25, 2021

In this encore episode, Stacey Richter talks with Mike Schneider about the “Big Three” PBMs — Express Scripts, Optum, and CVS Caremark — spinning up their own group purchasing organizations (GPOs) to negotiate rebates with pharma companies. Traditionally, GPOs negotiated volume discounts on drugs and supplies...

Nov 18, 2021

In Episode 345, Stacey Richter talks with Paul Simms, founder of Impatient Health and former chairman of eyeforpharma, about whether pharma can imagine what our health system will look like in the future. Paul argues that the sheer amount of money sloshing around the industry could actually be inhibiting R&D innovation...

Nov 11, 2021

In Episode 345, Stacey Richter talks with Paul Simms, founder of Impatient Health and former chairman of eyeforpharma, about whether pharma can imagine what our health system will look like in the future. Paul argues that the sheer amount of money sloshing around the industry could actually be inhibiting R&D innovation...

Nov 4, 2021

In Episode 344, Stacey Richter talks with Steven Quimby, MD, author of Billions in Your Generic Drugs, about why generic medications — 90% of all prescriptions written in this country — can still carry surprisingly high prices despite razor-thin costs of goods. Dr. Quimby explains the ongoing generic...